Use of NK1 knockout mice to analyze substance P-induced edema formation

被引:62
作者
Cao, T
Gerard, NP
Brain, SD
机构
[1] Kings Coll London, Sch Biomed Sci, Pharmacol Grp, London SW3 6LX, England
[2] Kings Coll London, Sch Biomed Sci, Vasc Biol Res Ctr, London SW3 6LX, England
[3] Childrens Hosp, Perlmutter Lab, Boston, MA 02115 USA
关键词
neurokinin-1; receptor; substance P; neurokinin-1 knockout mouse; edema formation; rat skin; tachykinins; neurokinins;
D O I
10.1152/ajpregu.1999.277.2.R476
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The mechanisms involved in tachykinin-induced neurokinin-1 (NK1) receptor-mediated edema formation have been studied in anesthetized wild-type and NK1 knockout mice. Intradermally injected substance P (30-300 pmol), NK1 agonists septide (3-30 pmol) and GR-73632 (3-30 pmol), and the mast cell-degranulating agent, compound 48/80 induced dose-dependent edema in wild-type skin, measured by the accumulation of intravenously injected I-125-labeled albumin. Septide was 3-10 X more potent than substance P. The tachykinins were inactive in knockout mice, but compound 48/80 induced a significantly greater edema (P < 0.05) than that observed in paired wild-type mice. Capsaicin (which releases endogenous neuropeptides) and exogenous tachykinins induced edema formation, which was reduced by the mast cell amine histamine ill antagonist mepyramine (P < 0.05). These findings confirm that tachykinins mediate edema formation via the NK1 receptor and provide direct evidence that the septide-sensitive binding site is on the NK1 receptor. Furthermore, results suggest that edema induced by the tachykinins, although totally dependent on NK1 receptor-mediated mechanism, contains a mast cell-dependent component. The evidence is in keeping with an NK1 receptor on mast cells.
引用
收藏
页码:R476 / R481
页数:6
相关论文
共 30 条
  • [21] KOWALSKI ML, 1990, J IMMUNOL, V145, P1214
  • [22] EVIDENCE OF NK1 AND NK2 TACHYKININ RECEPTORS AND THEIR INVOLVEMENT IN HISTAMINE-RELEASE IN A MURINE MAST-CELL LINE
    KRUMINS, SA
    BROOMFIELD, CA
    [J]. NEUROPEPTIDES, 1992, 21 (02) : 65 - 72
  • [23] LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282
  • [24] THE NONPEPTIDE TACHYKININ ANTAGONIST, CP-96,345, IS A POTENT INHIBITOR OF NEUROGENIC INFLAMMATION
    LEMBECK, F
    DONNERER, J
    TSUCHIYA, M
    NAGAHISA, A
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (03) : 527 - 530
  • [25] SUBSTANCE-P-INDUCED HISTAMINE-RELEASE IN TRACHEALLY PERFUSED GUINEA-PIG LUNGS
    LILLY, CM
    HALL, AE
    RODGER, IW
    KOBZIK, L
    HALEY, KJ
    DRAZEN, JM
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1995, 78 (04) : 1234 - 1241
  • [26] The dual nature of the tachykinin NK1 receptor
    Maggi, CA
    Schwartz, TW
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (10) : 351 - 355
  • [27] THE MAMMALIAN TACHYKININ RECEPTORS
    MAGGI, CA
    [J]. GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1995, 26 (05): : 911 - 944
  • [28] POSSIBLE EXISTENCE OF A NEW TACHYKININ RECEPTOR SUBTYPE IN THE GUINEA-PIG ILEUM
    PETITET, F
    SAFFROY, M
    TORRENS, Y
    LAVIELLE, S
    CHASSAING, G
    LOEUILLET, D
    GLOWINSKI, J
    BEAUJOUAN, JC
    [J]. PEPTIDES, 1992, 13 (02) : 383 - 388
  • [29] Exogenous but not endogenous substance P releases histamine from isolated human skin fragments
    Tausk, F
    Undem, B
    [J]. NEUROPEPTIDES, 1995, 29 (06) : 351 - 355
  • [30] ZIMMER A, 1998, NEUROBIOLOGY, V95, P2630